Bone Biologics (BBLGW) Total Liabilities (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Total Liabilities for 2 consecutive years, with $11.8 million as the latest value for Q3 2017.
- Quarterly Total Liabilities rose 53.23% to $11.8 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Sep 2017, up 53.23% year-over-year, with the annual reading at $9.1 million for FY2016, N/A changed from the prior year.
- Total Liabilities for Q3 2017 was $11.8 million at Bone Biologics, up from $10.5 million in the prior quarter.
- The five-year high for Total Liabilities was $11.8 million in Q3 2017, with the low at $7.5 million in Q1 2016.